Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing.
CPA4 (carboxypeptidase A4) is a member of the metallocarboxypeptidase family. CPA4 was originally found in a screen of mRNAs up-regulated by sodium butyrate-induced differentiation of cancer cells. Further studies suggested a relation between CPA4 and prostate cancer aggressiveness. In the present study, we determined that CPA4 is secreted from cells as a soluble proenzyme (pro-CPA4) that can be activated by endoproteases, such as trypsin. Three complementary approaches were used to study the substrate specificity of CPA4; kinetic analysis was performed using a new series of chromogenic substrates and some biologically relevant peptides, the cleavage of synthetic peptides was tested individually, and the cleavage of a mixture of >100 mouse brain peptides was examined using a quantitative peptidomics mass spectrometry-based approach. CPA4 was able to cleave hydrophobic C-terminal residues with a preference for Phe, Leu, Ile, Met, Tyr, and Val. However, not all peptides with C-terminal hydrophobic residues were cleaved, indicating the importance of additional residues within the peptide. Aliphatic, aromatic, and basic residues in the P1 position have a positive influence on the cleavage specificity. In contrast, acidic residues, Pro, and Gly have a negative influence in the P1 position. Some of the peptides identified as CPA4 substrates (such as neurotensin, granins, and opioid peptides) have been previously shown to function in cell proliferation and differentiation, potentially explaining the link between CPA4 and cancer aggressiveness. Taken together, these studies suggest that CPA4 functions in neuropeptide processing and regulation in the extracellular environment.
Tanco
Sebastian
S
Departament de Bioquimica, Institut de Biotecnologia i de Biomedicina, Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain.
Zhang
Xin
X
Morano
Cain
C
Avilés
Francesc Xavier
FX
Lorenzo
Julia
J
Fricker
Lloyd D
LD
D000818:Animals; D001921:Brain / Q000378:metabolism; D002268:Carboxypeptidases / Q000737:chemistry; D043422:Carboxypeptidases A / Q000737:chemistry*; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D051379:Mice; D010455:Peptides / Q000737:chemistry; D010843:Pichia / Q000378:metabolism; D017434:Protein Structure, Tertiary; D040901:Proteomics / Q000379:methods; D013379:Substrate Specificity
D010455:Peptides; D002268:Carboxypeptidases; C539656:CPA4, human; D043422:Carboxypeptidases A
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1743-7
19179285
Mol Immunol. 2008 Oct;45(16):4080-3
18706698
Anal Chem. 2008 Dec 1;80(23):9298-309
19551992
Anal Biochem. 1982 Sep 15;125(2):420-6
7181100
J Biol Chem. 1991 Dec 25;266(36):24606-12
1761558
J Biol Chem. 2008 Mar 14;283(11):7054-63
18178555
J Biol Chem. 2005 Feb 4;280(5):3441-8
15561703
J Biol Chem. 2000 Feb 18;275(7):4865-70
10671522
Hum Genet. 2003 Mar;112(3):220-6
12552318
Acta Crystallogr D Biol Crystallogr. 2008 Jul;D64(Pt 7):784-91
18566513
Cell Mol Life Sci. 2005 Sep;62(17):1996-2014
16091843
PLoS One. 2009;4(1):e4223
19156213
J Neurochem. 2008 Dec;107(6):1596-613
19014391
FASEB J. 2007 Mar;21(3):851-65
17244817
Prostate. 2007 Feb 1;67(2):190-202
17044078
FEBS Lett. 1997 Dec 22;420(1):7-10
9450539
Biochemistry. 1973 May 22;12(11):2070-8
4735879
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13838-43
9391114
Nature. 2007 Jan 11;445(7124):168-76
17151600
Curr Pharm Des. 2007;13(4):349-66
17311554
Crit Rev Biochem Mol Biol. 2008 Sep-Oct;43(5):319-45
18937105
Am J Hum Genet. 2000 Jul;67(1):92-9
10825281
Biochemistry. 1975 Jun 3;14(11):2410-9
237533
J Biol Chem. 2004 Jul 30;279(31):32339-44
15173164
Brain Res. 1997 Mar 21;751(2):330-5
9099823
Mol Cell Proteomics. 2005 Sep;4(9):1391-405
15970582
J Proteome Res. 2007 Dec;6(12):4667-76
17979226
Hum Gene Ther. 1999 Jan 20;10(2):235-48
10022548
Biochemistry. 2007 Jun 12;46(23):6921-30
17506531
FASEB J. 2007 Mar;21(3):836-50
17244818
EMBO J. 1997 Dec 1;16(23):6906-13
9384570
BMC Cancer. 2009 Feb 26;9:69
19245716
Methods Enzymol. 1995;248:59-84
7674947
J Biol Chem. 1974 Sep 10;249(17):5495-9
4415398
Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):132-42
15950771
Cell Mol Life Sci. 2008 Jan;65(2):237-52
17965832
Cell Mol Life Sci. 2007 Nov;64(22):2863-86
17717629
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D270-2
16381862
Adv Immunol. 2007;95:167-255
17869614
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3978-83
15738388
J Med Genet. 2003 Apr;40(4):249-56
12676894
Protein Eng Des Sel. 2008 Sep;21(9):545-51
18515300
Int J Urol. 2001 Feb;8(2):65-70
11240828
Adv Exp Med Biol. 1990;265:75-92
2165733
J Biol Chem. 1998 Dec 4;273(49):32927-33
9830043
Cancer Res. 1999 Jun 15;59(12):2981-8
10383164
Biochemistry. 1962 Mar;1:231-8
13892106
J Endocrinol Invest. 2005;28(11 Suppl International):141-5
16625864
ACS Chem Biol. 2009 Jul 17;4(7):503-25
19462983